Chase AIPricingFAQs
Display currency
Loading news…

Cequent Pharmaceuticals

ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
Cambridge, Massachusetts, United States Founded 2006 11-50 employees For Profit

Cequent is a biopharmaceutical company pioneering the development of novel therapeutics to prevent and treat a wide range of human diseases.

Cequent Pharmaceuticals was acquired by Marina Biotech in 2010 for $46M.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
0
Patents
1

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
2
Active products
9
Patents granted
1
Trademarks
0
Top patent class
Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
IT spend
$98.01K

Company Info

Founded
2006
Employees
11-50
Operating status
Closed
Company type
For Profit
Org types
company
Founders
1
News articles
10
HQ
Cambridge, Massachusetts, United States
Region
Greater Boston Area, East Coast, New England
Exit date
Apr 1, 2010
Closed
Jun 30, 2014

Signals & Scores

Heat score
Low
Trend (7d)
4.2
Trend (30d)
3.5
Trend (90d)
1.7

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Cequent Pharmaceuticals

Loading news…

FAQs about Cequent Pharmaceuticals

People who checked this page also checked these

Browse the full Acquirezy directory.
Cequent Pharmaceuticals - Company Profile, Full Acquisitions List, Funding and Investments